Insider Trading Thur 12/14/23

Notable purchases -- Buffett adds to OXY; notable sales -- President/CEO active in WM

Buyers:

• BANC Director bought 10,000 shares at $12.305 - $12.34 worth ~$123K.
• DEA Chairman bought 8,000 shares at $13.14 - $13.15 worth ~$105K.
• ET Co-CEO bought 50,000 shares at $13.185 - $13.20 worth ~$660K.
• FTK Director bought 54,859 shares at $3.19 - $3.53 worth ~$189K.
• GTLS Director bought 500 shares at $134.445 worth ~$67K.
• LOVE 10% owner Satori Capital bought 151,784 shares at $24.91 - $25.80 worth ~$3.9 mln.
• OXY 10% owner Warren Buffett's Berkshire Hathaway (BRK.A / BRK.B) bought another 10,482,162 shares worth approx. $589 mln.
• SJM Director bought 1,000 shares at $125.05 worth ~$125K.
• TEX Director bought 50,000 shares at $50.69 - $51.20 worth ~$2.6 mln.

Sellers:

• CCOI President / CEO sold 20,000 shares at $69.99 worth ~$1.4 mln.
• SF Senior Vice President & General Counsel sold 8,100 shares at $ 64.745 worth ~$524K.
• WM President / CEO sold 9,550 shares at $177.00 worth ~$1.7 mln.

-=Flotek Industries (FTK) to sell Florida Chemical To ADM (ADM) for $175 million

Sector: Energy
Industry: Oil & Gas Equipment & Services
Full Time Employees: 334
HQ: Houston, Texas
http://www.flotekind.com


Flotek Industries to sell Florida Chemical To ADM (ADM) for $175 million

• Co entered into a definitive agreement to sell Florida Chemical Company, its Consumer and Industrial Chemistry Technologies segment, to Archer Daniels Midland (ADM) for total consideration of $175 million in cash, subject to post-closing working capital and other adjustments.
• Following closing of the transaction, Flotek will focus its efforts on providing its global clients best-in-class solutions designed to maximize performance of their oil and gas wells, while simultaneously lowering well costs and fluid complexity. Flotek intends to use the net proceeds to pay off its credit facility balance of approximately $50 million. In addition, the Company is currently considering investing $20 million to $30 million in previously identified organic growth capital projects and will carefully review other future potential uses of the remaining funds.